Sensorineural hearing loss in patients with cystic fibrosis

Alan G Cheng1, Patrick R Johnston, Jennifer Luz

  • 1Department of Otolaryngology and Communication Enhancement, Children's Hospital Boston, and Department of Otology and Laryngology, Harvard Medical School, Boston, MA, USA. aglcheng@stanford.edu

Insights

Cystic fibrosis patients treated with aminoglycoside antibiotics face a high risk of developing sensorineural hearing loss (SNHL). Increased antibiotic courses correlate with a higher prevalence of SNHL in these patients.

Area of Science:

  • Otolaryngology
  • Pediatric Pulmonology
  • Clinical Pharmacology

Background:

  • Cystic fibrosis (CF) is a genetic disorder affecting multiple organs, including the auditory system.
  • Sensorineural hearing loss (SNHL) is a potential complication in CF patients, possibly linked to treatments.
  • Ototoxic medications, particularly aminoglycosides, are frequently used in CF management.

Purpose of the Study:

  • To investigate the prevalence of SNHL in pediatric CF patients.
  • To examine the association between SNHL and the cumulative use of potentially ototoxic antibiotics.

Main Methods:

  • Retrospective case series utilizing chart review.
  • Analysis of medical records from 50 CF patients at a tertiary care pediatric hospital (1994-2007).
  • Data included demographics, audiometric/tympanometric results, CF genotype, and antibiotic exposure (aminoglycosides, macrolides).

Main Results:

  • SNHL was identified in 14% (7/50) of CF patients.
  • A significant correlation was found between SNHL and the number of intravenous aminoglycoside courses (>10 courses associated with 43% SNHL prevalence, P<0.01).
  • Increased use of aminoglycosides via nasal irrigation (>5 courses associated with 23% SNHL prevalence, P<0.05) and macrolides (>5 courses associated with 60% SNHL prevalence, P=0.079) also showed trends towards higher SNHL risk.

Conclusions:

  • CF patients receiving aminoglycoside antibiotics are at elevated risk for SNHL.
  • Cumulative exposure to aminoglycosides, both intravenous and via nasal irrigation, is linked to increased SNHL incidence.
  • Further research into ototoxicity monitoring and alternative therapies in CF is warranted.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Unrenewable Cells00:50

Unrenewable Cells

In humans, the photoreceptor cells of the eye and sensory hair cells of the ear lack stem cells. These cells are thus unrenewable and cannot be replaced when they are damaged or destroyed.
Photoreceptors
The retina is composed of several layers and contains specialized cells called photoreceptors. The photoreceptors (rods and cones) change their membrane potential when stimulated by light energy. There are two types of photoreceptors—rods and cones—which differ in the shape of their outer...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...